Autor: |
Gang Wu, Shun Wang, Mian Cheng, Bin Peng, Jingjun Liang, He Huang, Xuejun Jiang, Lizhi Zhang, Bo Yang, Yongmei Cha, Hong Jiang, Congxin Huang |
Jazyk: |
angličtina |
Rok vydání: |
2016 |
Předmět: |
|
Zdroj: |
Clinics, Vol 71, Iss 5, Pp 251-256 (2016) |
Druh dokumentu: |
article |
ISSN: |
1980-5322 |
DOI: |
10.6061/clinics/2016(05)02 |
Popis: |
OBJECTIVES: This study investigated whether the serum matrix metalloproteinase-9 level is an independent predictor of recurrence after catheter ablation for persistent atrial fibrillation. METHODS: Fifty-eight consecutive patients with persistent atrial fibrillation were enrolled and underwent catheter ablation. The serum matrix metalloproteinase-9 level was detected before ablation and its relationship with recurrent arrhythmia was analyzed at the end of the follow-up. RESULTS: After a mean follow-up of 12.1±7.2 months, 21 (36.2%) patients had a recurrence of their arrhythmia after catheter ablation. At baseline, the matrix metalloproteinase-9 level was higher in the patients with recurrence than in the non-recurrent group (305.77±88.90 vs 234.41±93.36 ng/ml, respectively, p=0.006). A multivariate analysis showed that the matrix metalloproteinase-9 level was an independent predictor of arrhythmia recurrence, as was a history of atrial fibrillation and the diameter of the left atrium. CONCLUSION: The serum matrix metalloproteinase-9 level is an independent predictor of recurrent arrhythmia after catheter ablation in patients with persistent atrial fibrillation. |
Databáze: |
Directory of Open Access Journals |
Externí odkaz: |
|